P. Sadłecki

发表

KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system

P. Sadłecki, P. Antosik, D. Grzanka, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2014, PloS one.

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas

P. Sadłecki, D. Grzanka, M. Grabiec, 2018, Disease markers.

Deficiency of vitamin D in most common complications of pregnancy and periodontal disease in pregnant women - a review

P. Sadłecki, M. Walentowicz-Sadłecka, Maria Teresa Arias Moliz, 2019, Clinical Obstetrics, Gynecology and Reproductive Medicine.

[Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer].

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2011, Ginekologia polska.

[The role of vitamin D in the carcinogenesis of breast and ovarian cancer].

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2013, Ginekologia polska.

Human Adipose-Derived and Amniotic Fluid-Derived Stem Cells: A Preliminary In Vitro Study Comparing Myogenic Differentiation Capability

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2018, Medical science monitor : international medical journal of experimental and clinical research.

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2019, Disease markers.

The analysis of human leukocyte antigen‐G level in patients with endometrial cancer by Western blot technique

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2018, American journal of reproductive immunology.

Molecular diagnosis in type I epithelial ovarian cancer.

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2017, Ginekologia polska.

High Quality Independent From a Donor: Human Amniotic Fluid Derived Stem Cells—A Practical Analysis Based on 165 Clinical Cases

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2017, Journal of cellular biochemistry.

Serum 25(OH) Vitamin D Levels in Polish Women during Pregnancies Complicated by Hypertensive Disorders and Gestational Diabetes

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2016, International journal of molecular sciences.

Angiogenesis in neoplastic processes

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2010 .

Human amniotic fluid as a source of stem cells

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2022, Open medicine.

25(OH)D3 in patients with ovarian cancer and its correlation with survival.

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2012, Clinical biochemistry.

The Role of Wnt/Beta-Catenin Pathway, SATB1 and SATB2 in Endometrial Cancer Patients

P. Sadłecki, M. Walentowicz-Sadłecka, A. Marszałek, 2021 .

Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer

P. Sadłecki, P. Antosik, M. Walentowicz-Sadłecka, 2020, BioMed research international.

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers

P. Sadłecki, P. Antosik, D. Grzanka, 2019, Journal of Ovarian Research.

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2014, Expert opinion on biological therapy.

The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2014, BioMed research international.

Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2016, PloS one.

Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2014, PloS one.

Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers

P. Sadłecki, P. Antosik, M. Grabiec, 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testing

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2018, BMC Pregnancy and Childbirth.

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2013, International journal of endocrinology.

Serum epidermal growth factor levels in epithelial ovarian tumours

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2011 .

Prenatal diagnosis of fetal defects and its implications on the delivery mode

P. Sadłecki, M. Walentowicz-Sadłecka, 2023, Open medicine.

Prenatally Evolving Ectopia Cordis with Successful Surgical Treatment

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2011, Fetal Diagnosis and Therapy.

The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients

P. Sadłecki, M. Grabiec, M. Walentowicz-Sadłecka, 2014, BioMed research international.

Molecular landscape of borderline ovarian tumours: A systematic review

P. Sadłecki, M. Walentowicz-Sadłecka, 2024, Open Medicine.